Croda pushes deeper into drug ancillaries
2019; American Chemical Society; Volume: 97; Issue: 1 Linguagem: Inglês
10.1021/cen-09701-buscon10
ISSN2474-7408
Autores Tópico(s)Biosimilars and Bioanalytical Methods
ResumoCroda International has agreed to purchase Brenntag Biosector, a Danish adjuvants producer, from chemical distributor Brenntag Nordic for about $82 million. Biosector has a portfolio of aluminum- and saponin-based adjuvants, used to enhance the effectiveness of human and animal vaccines. The purchase includes a production facility in Frederikssund, Denmark. Croda already produces inert drug ingredients, known as excipients.
Referência(s)